Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Denosumab versus zoledronic acid in patients previously treated with zoledronic acid

• Athanasios D Anastasilakis, Stergios A Polyzos, +7 authors Polyzois Makras
• Osteoporosis International
• 2015

Denosumab and zoledronic acid are potent antiresorptives. In this study in patients pre-treated with zoledronic acid, denosumab achieved similar increases with zoledronic acid in lumbar spine BMD… (More)

Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum.

• Athina I Gkiomisi, Kali G. Makedou, +7 authors Charalambos Giannoulis
• Cytokine
• 2013

Although vaspin is regarded an insulin-sensitizing adipokine, its role in gestational diabetes mellitus (GDM) is currently unknown. We aimed to evaluate serum vaspin levels and their correlation with… (More)

Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months

• Athanasios D Anastasilakis, Stergios A Polyzos, +5 authors Christos Socrates Mantzoros
• Osteoporosis International
• 2014

In vitro data suggest that myokine irisin may affect bone metabolism by promoting osteoblast differentiation while inhibiting osteoclast differentiation. In this study, circulating irisin levels were… (More)

Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.

• Athanasios D Anastasilakis, Stergios A Polyzos, Athina I Gkiomisi, Ilias G Bisbinas, Spyridon Gerou, Polyzois Makras
• The Journal of clinical endocrinology and…
• 2013

CONTEXT Decreased bone formation due to a coupling effect limits bone mass increases after antiresorptive treatment. OBJECTIVE The purpose of this study was to compare the effects of 2 potent… (More)

Artificial nutrition and intestinal mucosal barrier functionality.

• Chrysostomos D. Anastasilakis, Orestis M. Ioannidis, Athina I Gkiomisi, Dimitrios Botsios
• Digestion
• 2013

The gastrointestinal tract has a major role in digestion and absorption of nutrients while playing a leading role in defense of the body. It forms a shield against the invasion of various… (More)

Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment.

• Athanasios D Anastasilakis, Stergios A Polyzos, +5 authors Evangelos Terpos
• Hormone and metabolic research = Hormon- und…
• 2014

Periostin is a secreted extracellular matrix protein preferentially expressed in bone by osteocytes and periosteal osteoblasts. Reduced periostin expression may affect osteoblast differentiation and… (More)

Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.

• Athanasios D Anastasilakis, Rosaria-Maddalena Ruggeri, +8 authors Stergios Papachatzopoulos
• Metabolism: clinical and experimental
• 2013

BACKGROUND Struma ovarii is a rare cause of hyperthyroidism, while coexistence with Graves' disease has been scarcely reported. PATIENT FINDINGS We report a patient with Graves' disease and… (More)

Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass.

• Athanasios D Anastasilakis, Stergios A Polyzos, +8 authors Socrates E Papapoulos
• Bone
• 2012

An acute phase response (APR) is frequently observed in patients treated with intravenous (i.v.) zoledronate (ZOL). We aimed to define clinical and laboratory parameters that may predict ZOL-induced… (More)

Oxidized low-density lipoprotein and adiponectin levels in pregnancy.

• Kali G. Makedou, Anargyros Kourtis, +6 authors Theodoros Agorastos
• Gynecological endocrinology : the official…
• 2011

INTRODUCTION The aim of the present study was to investigate whether normal pregnancy represents a complex state of oxidative stress, inflammation and insulin resistance. SUBJECTS AND METHODS One… (More)

Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.

• Athanasios D Anastasilakis, Stergios A Polyzos, +6 authors Evangelos Terpos
• Expert opinion on therapeutic targets
• 2015

OBJECTIVE The evaluation of circulating semaphorin-4D (sema4D) and plexin-B1 in postmenopausal women with low bone mass and the effect of antiresorptive or osteoanabolic treatment. METHODS Serum… (More)

• ‹
• 1
• 2
• ›